Patents by Inventor Marjo Pihlavisto

Marjo Pihlavisto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
    Publication number: 20040236108
    Abstract: The present invention is directed to carbocyclic hydrazino compounds that function as inhibitors of copper-containing amine oxidases commonly known as semicarbazide-sensitive amine oxidases (SSAO), including the human SSAO known as Vascular Adhesion Protein-1 (VAP-1). These SSAO inhibitors have therapeutic utility as drugs to treat conditions and diseases including, but not limited to, a number of inflammatory conditions and diseases (in particular chronic inflammatory conditions such as chronic arthritis, inflammatory bowel diseases, and chronic skin dermatoses), diseases related to carbohydrate metabolism and to aberrations in adipocyte differentiation or function and smooth muscle cell function, and vascular diseases.
    Type: Application
    Filed: June 30, 2004
    Publication date: November 25, 2004
    Inventors: David John Smith, Ferenc Fulop, Marjo Pihlavisto, Laszlo Lazar, Sakari Alaranta, Petri Vainio, Zsolt Szakonyi
  • Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
    Publication number: 20030125360
    Abstract: The present invention is directed to carbocyclic hydrazino compounds that function as inhibitors of copper-containg amine oxidases commonly known as semicarbazide-sensitive amine oxidases (SSAO), including the human SSAO known as Vascular Adhesion Protein-I (VAP-1). These SSAO inhibitors have therapeutic utility as drugs to treat conditions and diseases including, but not limited to, a number of inflammatory conditions and diseases (in particular chronic inflammatory conditions such as chronic arthritis, inflammatory bowel diseases, and chronic skin dermatoses), diseases related to carbohydrate metabolism and to aberrations in adipocyte differentiation or function and smooth muscle cell function, and vascular diseases.
    Type: Application
    Filed: July 12, 2001
    Publication date: July 3, 2003
    Applicant: Biotie Therapies Corp.
    Inventors: David John Smith, Ferenc Fulop, Marjo Pihlavisto, Laszlo Lazar, Sakari Alaranta, Petri Vainio, Zsolt Szakonyi